Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc > Which way will it go??

<< Previous

Bullboard Posts

Next >>

Comment by Chefboy69on Dec 20, 2023 8:58am

91 Views

Post# 35793440

RE:Which way will it go??

I think you already know the answer to that question. But what I'm more interested in is, when this goes back to the 30 or 40 Cent range will the people that pumped it again contact the CEO to try to get in on another private placement that never happened? These people are looking for warrants to dump on retail. I'm wondering if they're going to play that game again

<< Previous

Bullboard Posts

Next >>

This gambling tech stock might be the safest bet you’ll make this year